{ "cik": 1439222, "cik_padded": "0001439222", "entityName": "AGIOS PHARMACEUTICALS, INC.", "fiscal_years": [ { "accn": "0001439222-26-000025", "filed": "2026-02-12", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 4316000.0, "cash": 89130000.0, "eps_diluted": -7.12, "free_cash_flow": -377293000.0, "net_income": -412781000.0, "operating_cash_flow": -372977000.0, "operating_income": -472132000.0, "revenue": 54028000.0, "stockholders_equity": 1193114000.0, "total_assets": 1297225000.0, "total_liabilities": 104111000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.08725989301944324, "roa_avg2y": -0.2788661353914169, "roa_period_end": -0.318203087359556, "roe_avg2y": -0.30195349789873704, "roe_period_end": -0.3459694547210074 } }, { "accn": "0001439222-26-000025", "filed": "2026-02-12", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1685000.0, "cash": 76247000.0, "eps_diluted": 11.64, "free_cash_flow": -391526000.0, "net_income": 673725000.0, "operating_cash_flow": -389841000.0, "operating_income": -425737000.0, "stockholders_equity": 1540956000.0, "total_assets": 1663199000.0, "total_liabilities": 122243000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.07932932543174497, "roa_avg2y": 0.5181868210683543, "roa_period_end": 0.40507780488083506, "roe_avg2y": 0.5729014976774838, "roe_period_end": 0.4372123538894037 } }, { "accn": "0001439222-26-000025", "filed": "2026-02-12", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 999000.0, "cash": 88205000.0, "eps_diluted": -6.33, "free_cash_flow": -297061000.0, "net_income": -352088000.0, "operating_cash_flow": -296062000.0, "operating_income": -391487000.0, "revenue": 26823000.0, "stockholders_equity": 811019000.0, "total_assets": 937118000.0, "total_liabilities": 126099000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.1554821773595933, "revenue_growth_yoy": 0.8836376404494382, "roa_avg2y": -0.32363468570241505, "roa_period_end": -0.3757136241113713, "roe_avg2y": -0.3683250576802472, "roe_period_end": -0.43413039645187096 } }, { "accn": "0001439222-26-000025", "filed": "2026-02-12", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 4881000.0, "cash": 139259000.0, "eps_diluted": -4.23, "free_cash_flow": -314359000.0, "net_income": -231801000.0, "operating_cash_flow": -309478000.0, "operating_income": -389047000.0, "revenue": 14240000.0, "stockholders_equity": 1100814000.0, "total_assets": 1238718000.0, "total_liabilities": 137904000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.12527456954580882, "roa_avg2y": -0.17321500761828898, "roa_period_end": -0.1871297583469361, "roe_avg2y": -0.19374963692995914, "roe_period_end": -0.21057235827305976 } }, { "accn": "0001439222-25-000009", "filed": "2025-02-13", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 5741000.0, "cash": 203126000.0, "eps_diluted": 26.55, "free_cash_flow": -413061000.0, "net_income": 1604715000.0, "operating_cash_flow": -407320000.0, "operating_income": -378418000.0, "stockholders_equity": 1291975000.0, "total_assets": 1437736000.0, "total_liabilities": 145761000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.11282029451034269, "roa_avg2y": 1.4010768817054091, "roa_period_end": 1.1161402371506313, "roe_avg2y": 1.8974149780517005, "roe_period_end": 1.2420635074208093 } }, { "accn": "0001439222-24-000035", "filed": "2024-02-15", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 14106000.0, "cash": 127436000.0, "eps_diluted": -4.74, "free_cash_flow": -304865000.0, "net_income": -327370000.0, "operating_cash_flow": -290759000.0, "operating_income": -335916000.0, "stockholders_equity": 399500000.0, "total_assets": 852952000.0, "total_liabilities": 453452000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.1350488110137673, "roa_avg2y": -0.3754904102958491, "roa_period_end": -0.3838082330541461, "roe_avg2y": -0.6295407431338387, "roe_period_end": -0.8194493116395495 } }, { "accn": "0001439222-23-000039", "filed": "2023-02-23", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 12028000.0, "cash": 80931000.0, "eps_diluted": -6.86, "free_cash_flow": -382650000.0, "net_income": -411472000.0, "operating_cash_flow": -370622000.0, "operating_income": -316269000.0, "revenue": 117912000.0, "stockholders_equity": 640528000.0, "total_assets": 890741000.0, "total_liabilities": 250213000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.39063553818100066, "revenue_growth_yoy": 0.2492398317564919, "roa_avg2y": -0.4704693236557554, "roa_period_end": -0.46194348301021276, "roe_avg2y": -0.6196564174193281, "roe_period_end": -0.6423950241051134 } }, { "accn": "0001439222-22-000024", "filed": "2022-02-24", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 6986000.0, "cash": 70502000.0, "free_cash_flow": -311407000.0, "net_income": -346028000.0, "operating_cash_flow": -304421000.0, "operating_income": -362479000.0, "revenue": 94387000.0, "stockholders_equity": 687537000.0, "total_assets": 858457000.0, "total_liabilities": 170920000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.24859753002383872, "revenue_growth_yoy": 1.1944851317104928, "roa_avg2y": -0.46987413552191865, "roa_period_end": -0.4030813424551259, "roe_avg2y": -0.651015954244431, "roe_period_end": -0.5032863685881632 } }, { "accn": "0001439222-21-000029", "filed": "2021-02-25", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 4627000.0, "cash": 102724000.0, "free_cash_flow": -289859000.0, "net_income": -314670000.0, "operating_cash_flow": -285232000.0, "operating_income": -320794000.0, "revenue": 43011000.0, "stockholders_equity": 375503000.0, "total_assets": 614397000.0, "total_liabilities": 238894000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.6361973140028175, "revenue_growth_yoy": -0.3846076804212213, "roa_avg2y": -0.5102104514747169, "roa_period_end": -0.512160703909687, "roe_avg2y": -0.8573016534667223, "roe_period_end": -0.8379959680748224 } }, { "accn": "0001439222-20-000014", "filed": "2020-02-19", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 9915000.0, "cash": 160754000.0, "free_cash_flow": 28647000.0, "net_income": -198471000.0, "operating_cash_flow": 38562000.0, "operating_income": -200985000.0, "revenue": 69892000.0, "stockholders_equity": 358591000.0, "total_assets": 619094000.0, "total_liabilities": 260503000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.7264627388863636, "roa_period_end": -0.32058298093665905, "roe_period_end": -0.5534745713082593 } } ], "latest_filing": { "accn": "0001439222-26-000025", "filed": "2026-02-12", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001439222.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001439222.json" }, "ticker": "AGIO" }